News

The technology to be acquired facilitates rapid assay development and reduced costs for the end user. Co-Diagnostics president Dwight Egan said, "With this technology, we believe our highly

Hyperion Therapeutics president and CEO Donald Santel said that the orphan drug exclusivity further strengthens the protections for Ravicti. "Additionally, as we recently announced, we were issued a

Silenor, which is not a controlled substance, will be made available in 3mg or 6mg oral tablets. Paladin interim president and chief executive officer Mark Beaudet said, "Canadians

The US-based nutraceutical company said people who have an allergy or sensitivity to either allergen run the risk of serious or life-threatening allergic reaction if this product is

The LIMS system tracks the multiple next-generation sequencing (NGS) platform workflows from request with the help of secondary analysis. Sapio Sciences VP Kevin Cramer said, "We look forward

Everycell, developed by a team of cell health and aging experts in partnership with GMP manufacturers, consists of over 90 essential phytonutrients, vitamins and minerals that the body

The AB-rated phenoxybenzamine hydrochloride capsule is the authorized generic of Dibenzyline. Prasco chief executive officer Chris Arington said, "Patients and customers alike benefit from WellSpring’s commitment to maintaining

As per the deal, Batavia gains exclusive license to the technology developed at CellaGenics, an UvA Holding company. Batavia CEO Menzo Havenga said, "We are very pleased that

ACLIFORM/COPD is the second pivotal trial designed to assess the safety and efficacy of aclidinium bromide (LAMA) and formoterol fumarate (LABA) fixed dose combinations, delivered in the Pressair